Holly Dushkin, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Temple University School of Medicine
Medical School
Temple University Hospital
Residency
Temple University Hospital
Fellowship
American Board of Internal Medicine - Oncology
PA State Medical License Active through 2012
OH State Medical License Active through 2017
DC State Medical License Active through 2018
Fox Chase Cancer Center
Languages: English/Spanish
(215) 728-6900
7701 Burholme Ave
Philadelphia, Pennsylvania 19111
Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation.
Freedman, G. M., Li, T., Polli, L. V., Anderson, P. R., Bleicher, R. J., Sigurdson, E., Swaby, R., Dushkin, H., Patchefsky, A., Goldstein, L.; Breast J. 2012 Sep.
See more >>Impact of the radiation boost on outcomes after breast-conserving surgery and radiation.
Murphy, C., Anderson, P. R., Li, T., Bleicher, R. J., Sigurdson, E. R., Goldstein, L. J., Swaby, R., Denlinger, C., Dushkin, H., Nicolaou, N., Freedman, G. M.; Int J Radiat Oncol Biol Phys. 2011 Sep
See more >>Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation.
Arrangoiz, R., Papavasiliou, P., Dushkin, H., Farma, J. M.; Int J Surg Case Rep. 2011.
See more >>